Royal Philips is a Dutch healthcare and electronics conglomerate founded in 1891, headquartered in Amsterdam.
Is this your business? Add your evidence →
Philips demonstrates strong climate governance with SBTi-validated targets, 80% renewable energy, and A-list CDP scores across 11 years. However, operational emissions rose 5.81% in 2024, Scope 3 remains 537% above 2018 levels, and a massive product safety recall with ongoing DOJ/SEC scrutiny severely undermines credibility.
Royal Philips scores 48/100 (Making progress) on SINK's independent climate assessment, scored from public data only. Fees pay for the review, never the result. Last verified May 2026.
That places Royal Philips joint 198th of 847 companies scored, and joint 8th of 19 in Healthcare / Pharmaceuticals.
Where Royal Philips sits among healthcare / pharmaceuticals peers.
Among the 19 major healthcare / pharmaceuticals brands we've scored, Royal Philips is tied =8th of 19, with 1 other.
Its three lowest-scoring questions, and what the evidence didn't show.
Philips Respironics CPAP/BiPAP recall initiated June 2021; FDA Class I notice issued 2023. $479 million class action settlement (September 2023); $1.1 billion personal injury settlement (April 2024).
No verified net-positive biodiversity outcomes, no deforestation-free supply chain certification.
However, operational Scope 1+2 rose 5.81% year-on-year in 2024—an adverse trend.
A score changes when the evidence does. We use new published evidence at the next rescore. Evidence that isn't public can count through an evidence review.
Use this score in tenders
Send the link, or the one-page score sheet. It links back to this page and every source. Free.
Open the score sheet →Add your evidence, £99
Scored low because little is published? Send us your evidence. A person reviews it and your score reflects what you really do. Done within 5 working days.
Evidence review →Go tender-ready, £495 a year
A yearly rescore, a check of up to 25 key suppliers and a score badge for your website (coming soon).
Get in touch →Strongest on Carbon Footprint — Operations and Transparency & Accountability (8/10, 8/10). Weakest on Controversies & Red Flags and Nature & Biodiversity Impact (4/10, 5/10).
The 3 companies in the sector scoring nearest above Royal Philips.
Novartis demonstrates solid operational decarbonization and supply-chain engagement but relies heavily on carbon credits for claimed neutrality.
See the breakdown →Sanofi has delivered genuine absolute emission reductions (47% Scope 1&2, 10% Scope 3 vs 2019) and SBTi-validated net-zero targets to 2045.
See the breakdown →Roche has achieved strong operational decarbonisation (46% S1&2 reduction since 2022) and received SBTi validation for net-zero targets — a pharma first.
See the breakdown →The formula and all 18 sources.
Same ten questions for every company. No private weighting.
SINK = (0.3 × Base + 0.7 × Performance) × Scale18 sources used in this assessment. All publicly available. Each row shows which of the ten questions it informed.
12 of 18 sources are independent of the company.
If you believe a source has been misread or a newer version exists, submit a challenge.
Royal Philips is a Dutch healthcare and electronics conglomerate founded in 1891, headquartered in Amsterdam. The company manufactures medical devices, diagnostic imaging systems, patient monitoring equipment, and consumer health products. With 81,592 employees and €17.2 billion annual revenue, Philips ranks among Europe's largest diversified industrial manufacturers.
One email, every Sunday. Score changes, new research, the stories behind the numbers. Free.
No spam. Unsubscribe in one click.
Checking a company?
Search free →Asked to prove you're sustainable?
Get your business scored, free →Been scored?
See what's behind your number →Fees pay for the review, never the result.